Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

825425

registered interest
date	18/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pharmacy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effectiveness of the General Pharmaceutical Council's enforcement of standards for registered pharmacy premises; whether he has made an assessment of the effect of failure to apply such standards to pharmacy owners rather than only pharmacy professionals on the safety of patients; and if he will make a statement.
tabling member constituency	Rother Valley
tabling member printed	Sir Kevin Barron
uin	123566
answer	answer is ministerial correction date of answer 23/01/2018 answer text <p>The Department has not made any assessment of the effectiveness of the General Pharmaceutical Council (GPhC) as a regulator of pharmacy professionals and pharmacy premises. The Professional Standards Authority, which in its review of the GPhC’s performance in 2016-2017, found that the GPhC had met all of the standards for good regulation, including all of the standards for fitness to practise.</p><p> </p><p>Standards to safeguard the health, safety and wellbeing of patients and the public are set by the GPhC. It is important to note that there are very different legal frameworks for upholding these standards and how the regulator deals with these for pharmacy premises as compared to pharmacy professionals. 87% of the pharmacies inspected by the GPhC in 2016-17 were meeting all of the standards it sets. Any pharmacy not achieving all of the standards is required by the GPhC to implement an action plan to improve the services they provide. In this period the GPhC agreed 469 action plans with pharmacies to ensure they improved the services they provide, and 99% of them made the necessary improvements so that they were meeting all of the standards. In the same period 140 cases were made affecting an individual pharmacy professional’s registration.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 123567 question first answered 23/01/2018 17:21:47 answering member 4067 label Biography information for Steve Brine
tabling member	392 label Biography information for Sir Kevin Barron

825426

registered interest
date	18/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pharmacy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of whether the failure to apply sanctions for standards for pharmacy premises has resulted in a disproportionate number of individual pharmacist registrants who have been held to account for professional standards which may have been impacted by the working environment created by pharmacy owners; and if he will make a statement.
tabling member constituency	Rother Valley
tabling member printed	Sir Kevin Barron
uin	123567
answer	answer is ministerial correction date of answer 23/01/2018 answer text <p>The Department has not made any assessment of the effectiveness of the General Pharmaceutical Council (GPhC) as a regulator of pharmacy professionals and pharmacy premises. The Professional Standards Authority, which in its review of the GPhC’s performance in 2016-2017, found that the GPhC had met all of the standards for good regulation, including all of the standards for fitness to practise.</p><p> </p><p>Standards to safeguard the health, safety and wellbeing of patients and the public are set by the GPhC. It is important to note that there are very different legal frameworks for upholding these standards and how the regulator deals with these for pharmacy premises as compared to pharmacy professionals. 87% of the pharmacies inspected by the GPhC in 2016-17 were meeting all of the standards it sets. Any pharmacy not achieving all of the standards is required by the GPhC to implement an action plan to improve the services they provide. In this period the GPhC agreed 469 action plans with pharmacies to ensure they improved the services they provide, and 99% of them made the necessary improvements so that they were meeting all of the standards. In the same period 140 cases were made affecting an individual pharmacy professional’s registration.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 123566 question first answered 23/01/2018 17:21:47 answering member 4067 label Biography information for Steve Brine
tabling member	392 label Biography information for Sir Kevin Barron

824572

registered interest
date	17/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pharmacy: Disclosure of Information
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many Freedom to Speak up Guardians have been nominated in community pharmacies; and whether his Department holds information on names of those Guardians.
tabling member constituency	Rother Valley
tabling member printed	Sir Kevin Barron
uin	123373
answer	answer is ministerial correction date of answer 22/01/2018 answer text <p>The Department does not hold information on the number or names of Freedom to Speak up Guardians in community pharmacies.</p><p> </p><p>NHS England is responsible for issuing the guidance on Freedom to Speak Up in primary care and has provided the following response:</p><p> </p><p>The number and names of Freedom to Speak Up Guardians in community pharmacies is not held centrally. Guidance for primary care providers was published in November 2016 on the NHS England website and a number of models for Freedom to Speak Up are detailed within that guidance, including having a named Guardian who is independent of the line management chain and not a direct employee. NHS England is working with the National Guardian's Office to assess the support that primary care providers, including community pharmacies, may need to comply with this guidance.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 22/01/2018 17:23:23 answering member 4067 label Biography information for Steve Brine
tabling member	392 label Biography information for Sir Kevin Barron

824607

registered interest
date	17/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pharmacy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will review corporate governance and corporate social responsibility in the pharmacy sector.
tabling member constituency	Cardiff Central
tabling member printed	Jo Stevens
uin	123408
answer	answer is ministerial correction date of answer 22/01/2018 answer text <p>Ministers have no plans to review corporate governance or policies on corporate social responsibility in the pharmacy sector. Community pharmacies contracted to deliver National Health Service pharmaceutical services are private businesses. Standards to safeguard the health, safety and wellbeing of patients and the public are set by the General Pharmaceutical Council and pharmacy businesses, like all others, are subject to health and safety legislation that aims to protect the health, safety and welfare of staff.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 22/01/2018 17:20:45 answering member 4067 label Biography information for Steve Brine
tabling member	4425 label Biography information for Jo Stevens

823505

registered interest
date	16/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prescription Drugs: Prices
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 18 December 2017 to Question 119906, what steps he took to ascertain why the market price of amlodipine 5mg tablets was above the reimbursement price listed in the Drug Tariff prior to granting a concessionary price.
tabling member constituency	Fylde
tabling member printed	Mark Menzies
uin	122976
answer	answer is ministerial correction date of answer 19/01/2018 answer text <p>Before granting a concessionary price we contact suppliers to ascertain that the product was not available at or below the reimbursement price listed in the Drug Tariff. While a specific assessment was not made as to why this particular product was not available at or below the reimbursement price listed in the Drug Tariff, we are aware of a number of reasons for the pressure in the supply chain generally.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 19/01/2018 14:15:03 answering member 4067 label Biography information for Steve Brine
tabling member	3998 label Biography information for Mark Menzies

823525

registered interest
date	16/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prescriptions: Adoption Leave
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 16 January 2018 to Question 122208, if he will make it his policy to conduct an assessment of the potential merits of issuing maternity exemption certificates to people taking adoption leave.
tabling member constituency	Oxford West and Abingdon
tabling member printed	Layla Moran
uin	122994
answer	answer is ministerial correction date of answer 19/01/2018 answer text <p>The Department has no plans to undertake an assessment of the potential merits of issuing maternity exemption certificates to people taking adoption leave. Almost 90% of prescription items are free on the National Health Service in England and for those who do not qualify for an exemption, prescription prepayment certificates are available. A holder of a 12 month certificate can get all the prescriptions they need for just £2 per week.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 19/01/2018 14:16:04 answering member 4067 label Biography information for Steve Brine
tabling member	4656 label Biography information for Layla Moran

823710

registered interest
date	16/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Advisory Committee on Resource Allocation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the membership is of the Advisory Committee on Resource Allocation (ACRA); who the chair of ACRA is; and if he will place copies of the agendas for each of ACRA's last ten meetings, together with supporting papers, in the Library.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Luciana Berger
uin	123159
answer	answer is ministerial correction date of answer 19/01/2018 answer text <p>The Advisory Committee on Resource Allocation is chaired by Professor Peter Smith, Emeritus Professor of Health Policy at Imperial College Business School. The full list of members is in the table below.</p><p> </p><table><tbody><tr><td><p>Name</p></td><td><p>Organisation</p></td></tr><tr><td><p>Professor Peter C Smith – Chair</p></td><td><p>Emeritus Professor of Health Policy, Imperial College Business School</p></td></tr><tr><td><p>Dr Sheena Asthana</p></td><td><p>Professor of Health Policy, School of Law, Criminology and Government, University of Plymouth</p></td></tr><tr><td><p>Dr Janet Atherton</p></td><td><p>Public Health Consultant</p></td></tr><tr><td><p>Dr Chris Bentley</p></td><td><p>HINST Associates</p></td></tr><tr><td><p>Prof Gwyn Bevan</p></td><td><p>Professor of Policy Analysis, London School of Economics and Political Science</p></td></tr><tr><td><p>Bob Butcher</p></td><td><p>Department of Health</p></td></tr><tr><td><p>Ben Chilcott</p></td><td><p>Chief Finance Officer, Western Locality, NEW Devon CCG</p></td></tr><tr><td><p>Professor Richard Cookson</p></td><td><p>Centre for Health Economics, University of York</p></td></tr><tr><td><p>Dr Mike D’Souza</p></td><td><p>General Practitioner, Kingston Multi-fund GP consortium (Former)</p></td></tr><tr><td><p>Ben Day</p></td><td><p>Head of Financial Strategy and Allocations, NHS England</p></td></tr><tr><td><p>Dr Paul Edmondson-Jones</p></td><td><p>Director of Public Health, Redcar and Cleveland</p></td></tr><tr><td><p>Anna Everton</p></td><td><p>Senior Analytical Lead, Analysis and Insight for Finance, NHS England</p></td></tr><tr><td><p>Professor Brian Ferguson</p></td><td><p>Chief Economist, Public Health England</p></td></tr><tr><td><p>Dr Sunil Gupta</p></td><td><p>General Practitioner and Member of the Governing Body of Castlepoint and Rochford Clinical Commissioning Group</p></td></tr><tr><td><p>Professor Sir Brian Jarman</p></td><td><p>Emeritus Professor of Primary Care, Imperial College of Medicine</p></td></tr><tr><td><p>Tarryn Lake</p></td><td><p>Deputy Chief Finance Officer, NHS Sunderland Clinical Commissioning Group</p></td></tr><tr><td><p>Andrew Lloyd-Kendall</p></td><td><p>Head of Research, British Medical Association</p></td></tr><tr><td><p>Dr Stephen Lorrimer</p></td><td><p>Head of Analysis and Insight for Finance, NHS England</p></td></tr><tr><td><p>Professor Eugene Milne</p></td><td><p>Director of Public Health, Newcastle City Council</p></td></tr><tr><td><p>Nicola Morton</p></td><td><p>Head of Local Government Finance, Local Government Association</p></td></tr><tr><td><p>Dave Roberts</p></td><td><p>Head of Primary Care Information, NHS Digital</p></td></tr><tr><td><p>Professor Colin Sanderson</p></td><td><p>Professor of Operational Research in Health Care, London School of Hygiene and Tropical Medicine</p></td></tr><tr><td><p>Rob Shaw</p></td><td><p>Lead Analyst (Forecasting), Analytical Insight Resource Unit, NHS England</p></td></tr><tr><td><p>David Slegg</p></td><td><p>Director of Finance, London Regional Office, NHS England</p></td></tr><tr><td><p>Steve Smallwood</p></td><td><p>Head of Population Statistics Transformation Unit, Office for National Statistics</p></td></tr><tr><td><p>Professor Matt Sutton</p></td><td><p>Professor of Health Economics, University of Manchester</p></td></tr><tr><td><p>Jon Swift</p></td><td><p>NHS England, Director of Finance, North Yorkshire and the Humber</p></td></tr><tr><td><p>Dr Ian Trimble</p></td><td><p>Independent GP Adviser, NHS Rushcliffe Clinical Commissioning Group</p></td></tr></tbody></table><p> </p><p>NHS England has published historical summaries of previous meeting papers relating to 2016/17-2018/19 allocations. These relate to the papers discussed at the first three of the last ten ACRA meetings, held in October and November 2015 and February 2016. They are available at the following link under the sections ‘ACRA documents’ and ‘Research reports’:</p><p> </p><p><a href="https://www.england.nhs.uk/2016/04/allocations-tech-guide-16-17/" target="_blank">https://www.england.nhs.uk/2016/04/allocations-tech-guide-16-17/</a></p><p> </p><p>To collate the full meeting papers of the previous meetings would incur disproportionate cost. However NHS England expect to publish further historical summaries supporting the advisory committee's recommendations for 2019-20 allocations by the end of the financial year 2018-19.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 19/01/2018 14:17:51 answering member 4067 label Biography information for Steve Brine
tabling member	4036 label Biography information for Luciana Berger

822817

registered interest
date	15/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Diagnosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve the rate of early diagnosis of cancer.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	122500
answer	answer is ministerial correction date of answer 22/01/2018 answer text <p>To raise awareness of cancer symptoms and encourage people with symptoms to go to their doctor without delay, we have run 13 national Be Clear on Cancer awareness campaigns since 2010/11. A national respiratory symptoms campaign ran from April to the end of August 2017, focusing on the symptoms of a persistent cough and inappropriate breathlessness. The campaign covered lung cancer along with other conditions such as heart disease and lung disease.</p><p> </p><p>Public Health England has developed a pilot on the abdominal symptoms which can be a sign of a number of cancers. This ran in the East and West Midlands in February and March 2017. Working in partnership with Be Clear on Cancer, Cancer Research UK has piloted a campaign in the North West on increasing uptake of bowel cancer screening in January and March 2017.</p><p> </p><p>Bowel scope screening has been rolled out to 98% of centres in England and over 300,000 55 year-olds have been screened so far.</p><p> </p><p>As recommended by the UK National Screening Committee and the independent Cancer Taskforce, we are modernising our world renowned cancer screening programmes by introducing Faecal Immunochemical Testing into the NHS Bowel Cancer Screening Programme during 2018/19 and human papillomavirus as the primary test in the NHS Cervical Screening Programme by December 2019.</p><p> </p><p>NHS England’s Accelerate, Co-ordinate, Evaluate (ACE) programme is testing innovative ways of diagnosing cancer earlier, with ACE Wave 2 piloting multi-disciplinary diagnostic centres for patients with vague or non-specific symptoms. The pilots are taking place in London, Greater Manchester, Leeds, Bristol, Oxfordshire and Airedale, Wharfedale and Craven (Yorkshire).</p><p> </p><p>The National Institute for Health Care and Excellence updated referral guidelines for suspected cancer published in June 2015 could save about 5,000 lives a year with general practitioners urged to think of cancer sooner and lower the referral threshold for tests.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 22/01/2018 11:49:46 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

822827

registered interest
date	15/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hepatitis: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans he has to discuss with the pharmaceutical industry steps to ensure that all patients who suffer from Hepatitis C have access to the full range of available medicines.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	122510
answer	answer is ministerial correction date of answer 23/01/2018 answer text <p>Currently, patients with chronic hepatitis C have access to all National Institute of Health and Care Excellence (NICE) approved hepatitis C treatments where clinically appropriate in line with current NICE guidance. Procurement of hepatitis C drugs is already undertaken every six months and this process involves discussion with industry regarding improving the cost to the National Health Service of these treatments. NHS England is continuing its work with industry on the prospects for a different approach to procurement which would further improve cost of these treatments.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 23/01/2018 14:11:09 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

822842

registered interest
date	15/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Alcoholic Drinks: Minimum Unit Prices
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential effect of minimum unit pricing on alcohol-related hospital admissions.
tabling member constituency	Birmingham, Edgbaston
tabling member printed	Preet Kaur Gill
uin	122525
answer	answer is ministerial correction date of answer 18/01/2018 answer text <p>Public Health England published an evidence review on the public health impact of alcohol and the effectiveness of policies for reducing alcohol-related harm in December 2016. The review concluded that reducing the affordability of alcohol is the most effective way of reducing alcohol harm, including hospital admissions and deaths, and targeted pricing measures are particularly effective at reducing harm in those groups most at risk.</p><p> </p><p>The review also found that targeting price increases at the cheapest alcohol is very effective and cost-effective and is able to substantially reduce harm in heavy drinkers without affecting moderate drinkers or the price of alcohol sold in pubs and bars. Modelling studies by the University of Sheffield on the impact of minimum unit price was shown to have a positive impact in closing the health inequalities gap between those in the highest and those in the lowest socioeconomic groups. These studies are available at:</p><p> </p><p><a href="https://www.sheffield.ac.uk/polopoly_fs/1.661445!/file/Final_mup_iba_report.pdf" target="_blank">https://www.sheffield.ac.uk/polopoly_fs/1.661445!/file/Final_mup_iba_report.pdf</a></p><p> </p><p>Minimum unit pricing and its effects will continue to remain under review pending the impact of its implementation in Scotland.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 18/01/2018 16:46:23 answering member 4067 label Biography information for Steve Brine
tabling member	4603 label Biography information for Preet Kaur Gill